Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.

This study suggests a role for uPAR as a biomarker to single out higher risk subgroups of patients with pancreatic cancer.
PMID: 28690396 [PubMed]

Source: Biomarker Insights - July 13, 2017 Category: General Medicine Authors: de Geus SW, Baart VM, Boonstra MC, Kuppen PJ, Prevoo HA, Mazar AP, Bonsing BA, Morreau H, van de Velde CJ, Vahrmeijer AL, Sier CF Tags: Biomark Insights Source Type: research